Join a clinical study investigating a treatment for alopecia areata
If you have moderate to severe alopecia areata, talk to your doctor about participating in a clinical research study of a potential treatment for the disease.
The purpose of this research study is to evaluate the safety and effectiveness of two investigational medications, in tablet form, or placebo, for alopecia areata.
You may qualify for participation if you:
- Are between 18 and 75 years old,
- Have moderate to severe alopecia areata,
- Have been experiencing hair loss for 7 years or less, and
- Are willing to follow a treatment plan of routinely scheduled study visits, lab tests and other study procedures for the duration of the study, up to 37 weeks, and
- You can avoid prolonged exposure to the sun or ultraviolet light during the study period.
For eligible study participants, all investigational medication (or inactive placebo), study-related tests and study doctor’s visits will be provided at no cost to you for the duration of the study, up to 37 weeks. Participation is voluntary and you may withdraw at any time.
For more information about this study, please contact:
- Miss Megan DeFazio
Level 2, 2 Wellington Parade,
East Melbourne, 3002
phone: (03) 9654 2426
If you are not eligible for the trial, but would like an expert assessment and discussion of your treatment options, ask your GP for a referral and telephone Sinclair Dermatology on (03) 96542426 for an appointment. Consultations are eligible for Medicare rebates. Out of pocket fees may apply.